<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-clindamycin.xml</id>
  <title>Recalls Watch: Clindamycin</title>
  <link rel="self" href="https://recalls.watch/feed/substance-clindamycin.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-08-19T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99526/</id>
    <title>Heritage Pharmaceuticals Inc: CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION</title>
    <link href="https://recalls.watch/recall/fda/99526/"/>
    <updated>2026-08-19T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98062/</id>
    <title>SUN PHARMACEUTICAL INDUSTRIES INC: Clindamycin Phosphate USP</title>
    <link href="https://recalls.watch/recall/fda/98062/"/>
    <updated>2026-01-21T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96764/</id>
    <title>RemedyRePack Inc.: Clindamycin HCl Capsule</title>
    <link href="https://recalls.watch/recall/fda/96764/"/>
    <updated>2025-05-14T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96756/</id>
    <title>Preferred Pharmaceuticals, Inc.: Clindamycin Hydrochloride Capsules</title>
    <link href="https://recalls.watch/recall/fda/96756/"/>
    <updated>2025-05-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: cGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96627/</id>
    <title>RemedyRepack Inc.: Clindamycin HCl</title>
    <link href="https://recalls.watch/recall/fda/96627/"/>
    <updated>2025-04-30T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96474/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Fenofibrate Capsules 67 mg and 38 more</title>
    <link href="https://recalls.watch/recall/fda/96474/"/>
    <updated>2025-04-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94066/</id>
    <title>Contract Pharmaceuticals Limited Canada: Clindamycin Phosphate and 1 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94066"/>
    <updated>2024-03-13T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.</summary>
  </entry>
</feed>
